1.Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Böhm M et al. 2013 ESH/ESC Practice Guidelines for the Management of Arterial Hypertension. Blood Pressure. 2013;23(1):3-16.
2.Ralapanawa U,Dharmaratne SD,Jayawickrema KP,Ekanayake M. Epdemiology of newly diagnosed hypertensives in a tertiary care hospital in a developing country.Clinical and Experimental Hypertension.2017;39 (3):251-256.
3. Jayawardana NWIA,Jayalath WATA,Madhujith WMT,Ralapanawa U,Jayasekera RS, Alagiyawanna SASB, Bandara AMKR, Kalupahana NS. Aging and obesity are associated with undiagnosed hypertension in a cohort of males in the central province of Sri Lanka:a cross-sectional descriptive study. BMC Cardiovascular Disorders 2017;17:165
DOI 10.1186/s12872-017-0600-8
4.Katarzyna Sawicka, Michał Szczyrek, Iwona Jastrzębska, Marek Prasał, Agnieszka Zwolak, Jadwiga Daniluk. Hypertension – The Silent Killer. Journal of Pre-Clinical and Clinical Research, 2011, Vol 5, No 2, 43-46
5.Narváez I, Iriarte JA, Lafuente PJ, Sáez Y,Sárz de Lafuente JP
Arterial hypertension as a cardiovascular risk factor in an elderly community of low social condition. Journal of Clinical and Basic Cardiology 2001; 4 (3), 225-227
6.Yoon SS, Fryar CD, Carroll MD.Hypertension Prevalence and Control Among Adults: United States, 2011–2014.NCHS Data Brief, No. 220, November 2015
7.Geraci T, Geraci S. Considerations in Women with Hypertension. Southern Medical Journal. 2013;106(7):434-438.
8.NVSS - Mortality Tables. Cdc.gov. 2016 [cited 12 October 2016]. Available from: http://www.cdc.gov/nchs/nvss/mortality_tables.htm
9. Sliwa K, Ojji D, Bachelier K, Böhm M, Damasceno A, Stewart S. Hypertension and hypertensive heart disease in African women. Clin Res Cardiol (2014) 103:515–523. DOI 10.1007/s00392-014-0660-z
10.Singh R. Isolated systolic hypertension. Medicine Update 2012- Vol. 22
11. Belletti D, Zacker C, Wogen J. Effect of cardiometabolic risk factors on hypertension management: a cross-sectional study among 28 physician practices in the United States. Cardiovasc Diabetol. 2010;9(1):7.
12. August P, Oparil S. Hypertension in Women. The Journal of Clinical Endocrinology & Metabolism 1999:84(6):1862-1866.
13. Gudmundsdottir H, Høieggen A , Stenehjem A, Waldum B, Os I. Hypertension in women: latest findings and clinical implications. Therapeutic Advances in Chronic Disease. 2012;3(3) 137–146.
DOI: 10.1177/ 2040622312438935
14. Akl C, Akik C, Ghattas H,Obermeyer CM. Gender disparities in midlife hypertension:
a review of the evidence on the Arab region.Women’s Midlife Health 2017;3(1)
DOI 10.1186/s40695-017-0020-z
15. Geraci TS, Geraci SA. Considerations in Women with Hypertension. Southern Medical Journal 2013;106( 7):434-438.
DOI: 10.1097/SMJ.0b013e31829bad37
16. Safar ME,Smulyan H. Hypertension in Women. American Journal of Hypertension 2004;17:82-87.
Doi:10.1016/S0895-7061(03)01008-2
17. Gillis EE,Sullivan JC. Sex Differences in Hypertension Recent Advances. Hypertension. 2016;68:1322-1327.
DOI: 10.1161/HYPERTENSIONAHA.116.06602.
18.Wilbert S. Aronow, Jerome L. Fleg, Carl J. Pepine, et al.
ACCF/AHA 2011 Expert consensus document on hypertension in the elderly (Circulation. 2011;123: 2434-2506.) Circulation is available at http://circ.ahajournals.org DOI: 10.1161/CIR.0b013e31821daaf6
19.WHO | The global burden of disease: 2004 update.Who.int. 2016 [cited 12 October 2016]. Available from: http://www.who.int/healthinfo/global_burden_disease/2004_report_update/en/
20.Global status report on noncommunicable diseases 2010 [Internet]. World Health Organization. 2016 [cited 14 October 2016]. Available from: http://www.who.int/nmh/publications/ncd_report2010/en/
21.Sri Lanka [Internet]. World Health Organization. 2016 [cited 14 October 2016]. Available from: http://www.who.int/countries/lka/en/
22.Department of Census and Statistics Sri Lanka. Census of population and housing. Percentage distribution of population according to district by population, 2012. Available from: http://www.statistics.gov.lk/pophousat/cph2011/pages/activities/reports/cph_2012_5per_rpt.pdf [last accessed 14 October 2016].
23.WHO Report on the Global Tobacco Epidemic, 2015.Country profile
Sri Lanka [Internet]. Who.int. 2016 [cited 14 October 2016]. Available from: http://www.who.int/tobacco/surveillance/policy/country_profile/lka.pdf?ua=1
24.Global Alcohol Report, Country profile. Sri Lanka [Internet]. 2016 [cited 14 October 2016]. Available from: http://www.who.int/substance_abuse/publications/global_alcohol_report/profiles/lka.pdf
25.Stegenga H, Haines A, Jones K, Wilding J. Identification, assessment, and management of overweight and obesity: summary of updated NICE guidance. BMJ. 2014;349(nov27 2):g6608-g6608.
26.American Heart Association Recommendations for Physical Activity in Adults [Internet]. Heart.org. 2016 [cited 14 October 2016]. Available from: <href="#.WABQ_eV97eg">http://www.heart.org/HEARTORG/HealthyLiving/PhysicalActivity/FitnessBasics/American-Heart-Association-Recommendations-for-Physical-Activity-in-Adults_UCM_307976_Article.jsp#.WABQ_eV97eg
27. Costa FV. Non-pharmacological treatment of hypertension in women. Journal of Hypertension 2002; 20 (2):s57-s61
28.Chatha G. Journal of Lancaster General Health - Breastfeeding and Maternal Risk of Cardio Metabolic Disease [Internet]. Jlgh.org. 2016 [cited 14 October 2016]. Available from: http://www.jlgh.org/Past-Issues/Volume-10---Issue-1/Breastfeeding-and-Maternal-Risk-of-Cardio-Mataboli.aspx
29.Ram K, Bobby P, Hailpern S, Lo J, Schocken M, Skurnick J et al. Duration of lactation is associated with lower prevalence of the metabolic syndrome in midlife—SWAN, the study of women’s health across the nation. American Journal of Obstetrics and Gynecology. 2008;198(3):268.e1-268.e6.
30.JNC 8 Hypertension Guideline Algorithm [Internet]. 2016 [cited 14 October 2016]. Available from: http://www.nmhs.net/documents/27JNC8HTNGuidelinesBookBooklet.pdf
31.Kaplan N, Bakris G, Forman J. Effect of oral contraceptives and postmenopausal hormone therapy on blood pressure [Internet]. Uptodate.com. 2016 [cited 14 October 2016]. Available from: http://www.uptodate.com/contents/effect-of-oral-contraceptives-and-postmenopausal-hormone-therapy-on-blood-pressure
32.Drost JT,Maas AHEM,van Eyck J,van der Schouw YT. Preeclampsia as a female-specific risk factor for chronichypertension.Maturitas 2010;67(4):321-6.
doi: 10.1016/j.maturitas.2010.08.002. Epub 2010 Sep 15.
33. Hwang JW, Park SJ, Oh SY, Chang SA, Lee SC,Park SW, Kim DK. The Risk Factors That Predict Chronic Hypertension AfterDelivery in Women With a History of Hypertensive Disorders of Pregnancy.Medicine(Baltimore)2015;94(42):e1747.
doi: 10.1097/MD.0000000000001747
34.Ranasinghe P,Cooray DN,Jayawardena R,Katulanda P. The influence of family history of Hypertension on disease prevalence and associated metabolic risk factors among Sri Lankan adults.BMC Public Health 2015;15:576.
doi: 10.1186/s12889-015-1927-7
35.Boldo A, White W. Blood Pressure Effects of the Oral Contraceptive and Postmenopausal Hormone Therapies. Endocrinology and Metabolism Clinics of North America. 2011;40(2):419-432.
36.Engelgau M, Okamoto K, Navaratne K, Gopalan S. [Internet]. Openknowledge.worldbank.org. 2016 [cited 14 October 2016]. Available from: https://openknowledge.worldbank.org/bitstream/handle/10986/13607/575630WP0Box351DS0SriLanka01PUBLIC1.pdf?sequence=1&isAllowed=y